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1. Introduction
The use of polymeric materials in medical devices and pharmaceutical applications has been
extended in the last decades. Biodegradable implantable polymers for tissue engineering
and drug release have the advantage to avoid a permanent and chronic immune response,
and to avoid removal surgery; moreover the versatility of polymeric materials aloud the de‐
sign of specific biodegradable characteristics to control drug release, to develop resorbable
devices, and to improve cell integration.
Biodegradation is a term used to describe the process of break down a material by nature;
however in the case of medical purpose biomaterials, biodegradation is focus in the biologi‐
cal processes inside the body that cause a gradual breakdown of the material.
Biomaterials degradation is a very important aspect to consider when they are used for
medical purpose, since their ability to function for a certain application depends on the
length of time that it is necessary to keep them in the body.
Polymers biodegradation process and rate within an organism is related to the polymer
characteristics and the place in the body where will be exposed. This chapter intended to of‐
fer an overview of the mechanisms that influences the biodegradation of polymeric materi‐
als used for medical purposes, with special emphasis in the immunological mechanisms that
modulates biodegradation rates and biocompatibility, and in the features that implies their
use in the central nervous system (CNS). It will be also focused in the importance of modu‐
late the biodegradation for some biomedical application, and how the on purpose control of
biodegradation could be a relevant aspect to design biomaterials with a more interactive
and efficient role in medicine.
© 2013 Tamariz and Rios-Ramírez; licensee InTech. This is an open access article distributed under the terms
of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
2. Polymeric material for biomedical applications
The use of polymers in biomedical applications is now widely accepted and they are termed
with the generic name of polymeric biomaterials. A biomaterial can be defined by their
function as a material in contact with living tissue, used to the treatment of disease or injury,
and to improve human health by restoring the function of tissue and organs in the body [1].
The 1982 Consensus Development Conference Statement of the National Institute of Health
(NIH) defines a biomaterial as any substance (other than drug) or combination of substances,
synthetic or natural in origin, which can be used for any period of time, as a whole or as a part
of a system which treats, augments or replaces any tissue, organ or function in the body [2].
Polymeric biomaterials in medicine include surgical sutures, drug delivery vectors, orthopedic
devices and implants, and scaffolds for tissue engineering.
After decades of research many polymeric biomaterials have been developed from synthetic
or natural origin. All the polymeric biomaterials have to be evaluated in terms of their
biocompatibility, mechanical properties and biodegradation to determine if they are suitable
for specific medical applications.
Biocompatibility refers to several characteristics of the biomaterial which leads to the accept‐
ance of the material in the body, such as being non toxic, non carcinogenic, non allergenic, non
immunogenic. The materials for in vivo use have to be exposed to hemocompatibility,
citotoxicity, mutagenicity, and pyrogenicity test [1].
Mechanical properties like elastic modulus, compression modulus, fatigue, and viscoelasticity
are important characteristics to determined their use in the body, for example for bone implants
and prosthesis; however micrometric or nanometric characterization is also important in the
case of biomaterials for tissue replacement and cell scaffolds, since micro and nano-character‐
istics are important to manipulate cell proliferation, differentiation, and function to mimic the
tissue to be replaced [3].
Biodegradation refers to the rate of breakdown mediated by biological activity, and is an
important property for biomaterials used as non permanent scaffolds, implants, drug delivery
vectors, and sutures [1].
The most commercial and earliest developed polymers for biomedical applications were the
synthetic polymers developed from linear aliphatic polyesters. Synthetic polymers are made
by linking small molecules (mers) through primary covalent binding in the main molecular
chain backbone, and have a close resemble with natural occurring tissue components like
proteins, polysaccharides and deoxyribonucleic acids. Besides synthetic polymers, natural
occurring polymers are also used as biomaterials. Many of the natural polymers are synthe‐
sized by condensation reactions and the condensing molecule is always the water [4]. Natural
polymers and their chemical and mechanical properties specifically provide functions to each
of them in the organisms, for example collagen in the dermis, fibrin in the clot, chitin in the
exoskeleton of insects and crustaceans [5, 6].
Either synthetic and natural polymers, or bonds among both has been studied and used as
materials for medical application; below we shortly describe some examples of the main
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natural and synthetic polymers and some of their proposed uses in medicine, particularly in
the nervous system.
2.1. Natural polymers
Natural polymers are used in clinical applications such as dermal fillers, lubricants, wound
sealants and surgical sponges. Other naturally derived polymers have readily available
functional groups which facilitate chemical modification.
Agarose is a polysaccharide of D-galactose and 3,6- anhydro-L-galactopyranose derived from
the cell walls of red algae. Agarose is biologically inert and is attractive for drug delivery
because it has soft, tissue-like mechanical properties, and can form porous gels at low tem‐
peratures. Agarose is heated to solubilize the powder in aqueous solutions and then gels
through hydrogen bonding upon cooling [7]. Agarose decrease potential immune rejection
when inserted into the brain, for example, Brain-derived neurotrophic factor (BDNF) delivered
in this way was found to reduce the reactivity of the astrocytes and the production of chon‐
droitin sulfate proteoglycans (CSPGs), and to enhance the number of regenerating fibers that
entered the hydrogel into the injured spinal cord in rats [7, 8].
Fibrin is a promising material because of its natural role in wound healing and its current
application as a tissue sealant. Obtained from pooled human plasma, fibrin presents an
advantage since it could be an autologous source avoiding risk of immune rejection. The most
used gel is the fibrin glue and consist of fibrinogen and thrombin enzymatically crosslinked;
however it has also used in conjugation with other polymers such as hyaluronic acid [1, 9].
This polymer has the advantage to be injected and polymerized in situ and has been tested for
controlled delivery of Nerve growth factor (NGF), Neurotrophin -3 (NT-3) and BDNF in the
CNS [7].
Collagen is the main component of connective tissue and is the most abundant protein in
mammals, there are at least 19 different types of collagen, for example type I collagen is a fibril
forming collagen and is present in the skin and fibrocartilage, type II collagen is found in
articular cartilage[10, 11]. Collagen can be isolated from tissue like skin, bone or tendon.
Collagen gels alone are quite weak, and are often crosslinked to improve durability. While
many applications use unmodified collagen, chemical crosslinkers can be used to inhibit in
vivo absorption in applications which require slow degrading constructs, such as drug
delivery [7, 12]. Although collagen is abundant in many tissues, is not the main component in
the CNS extracellular matrix, therefore some concern is present about their use as CNS cells
scaffolds [12], however their use for stably releasing of growth factors like ciliary neurotrophic
factor (CNTF), has shown to improve the survival, growth and proliferation of neural stem/
progenitor cells (NSPCs) [1].
Alginate is a linear block copolymer of D-mannuronic acid (M) and L-guluronic acid (G)
residues. Commercially available, alginate is extracted from brown seaweed algae. Alginate
has a high biocompatibility since their hydrophobic nature; however, cannot be enzimatically
broken down and has poorly regulated degradation. Partial oxidation of alginate with sodium
periodate makes the chains more susceptible to be degraded by hydrolysis [13]. Mammalian
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cells cannot adhere to alginate unless it is modified with cellular adhesion molecules like
laminin, fibronectin, collagen, and RGD sequences, which allow more specific interactions [9].
Covalently modified gels of alginate containing different ration of RGD peptides have been
used to encapsulate cells and to induce their differentiation [14].
Hyaluronic acid (HA) is a glycosamine glycane made of residues of N-acetylglucosamine and
D-glucuronic. HA is normally presented at high levels in the extracellular matrix of connective,
epithelial and neural tissues, and is known to play roles in cellular processes like cell prolif‐
eration, morphogenesis, inflammation, and wound repair. However, HA alone does not gel
and is rapidly degraded through the action of the enzyme hyaluronidase into smaller oligo‐
sacharides, HA can also be degraded by reactive oxygen species at the site of inflammation
[15], and is readily cleared due to its high solubility [1]. HA is fabricated into hydrogels using
chemical crosslinkers such as glutaraldehyde or carbodiimide, and has also been widely
derivatized to form photocrosslinkable and injectable hydrogels. Its polyanionic and hydro‐
philic characteristics made it highly biocompatible and suitable for applications with minimal
cell invasion [9].
Poly(β-1,4-D-glucosamine) or Chitosan is a natural polymer that can be prepared by de-N-
acetylation of chitin from crustacean shells, the degree of chitosan deacetylation affects the
charge density of the polysaccharide, more deacetylation increase the positive-charge charac‐
ter of the chitosan chains. It can form gels by covalent crosslinking with aldehydes such as
glutaraldehyde or ionic crosslinking by polyanions such as sodium citrate or sodium tripoly‐
phosphate [6]. The limited solubility of chitosan in neutral pH provides a unique opportunity
to form nanoparticulate drug/gene delivery platforms, but it is also an obstacle if one intends
to apply chitosan as a solution in the physiological condition [5]. Chitosan can be easily
conjugated with organic materials as well as biomolecules, a number of studies have reported
controlled drug delivery using chitosan nanoparticles that incorporate biologically active
ingredients such as DNA, proteins, anticancer drugs, and insulin [16]. Chitosan has been
extensively investigated as a potential biomaterial in a variety of applications, including drug
carriers, wound-healing agents, and in tissue engineering. Chitosan scaffolds have been used
to transplant viable peripheral nerve grafts, neural stem cells, and neural progenitor cells into
rat spinal cords, resulting in increased axonal regeneration [17].
Methylcellulose (MC) is a chemically modified cellulose derivative in which there is a partial
substitution of OH groups with methoxy moieties forming a non-toxic material. MC is a water-
soluble polymer at low temperature with thermo reversible gelation at a particular tempera‐
ture. Thermoreversible characteristics are related to the association of MC hydrophobic
groups, and the gelation temperature can be manipulated by salts or ions [18]. MC is widely
accepted as a highly compatible material and has been used in traumatic CNS lesion like a
scaffold for tissue regeneration [19].
2.2. Synthetic polymers
Synthetic polymers offer exceptional control over polymer composition, architecture, and
physical properties not fully accessible with natural polymers. After many years of research
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in this field numerous polymers have developed like polyesters, polyurethanes, polyanhy‐
drides, polyacrylates, polyphosphoesters, and polydiaxanone. One of the first and now most
common uses of polymers in medicine is for resorbable sutures, pins and screws. An extensive
review of synthetic polymers is out of this chapter and we will only mention some examples
and their main characteristics.
2.2.1. Polyesters
Polyglycolide or polyglycolic acid (PGA) is polymerized from glycolic acid and many of the
most important polymer for biomedical use are derived from PGA either through copolymer‐
ization or modified glicolide monomers. PGA is one of the most successful and commercially
available polymers and is widely used as biodegradable biomaterial in surgery [20].
Poly(lactide-co-glycolide) acid (PLGA) is a PGA derived polymer, is a polyesters obtainable
by linear polycondensation of hydroxyacids, or by ring opening of the corresponding lactones.
It is the most commonly used biomaterial in medicine. This polymeric agent has been im‐
planted into the brain and has shown good biocompatibility and sustainable drug delivery [8].
In normal untreated animals, polymer microspheres implanted into the brain did not produce
gross behavioral or neurological symptoms, and it has been approved for the FDA for repair
of human peripheral nerves [5]. Various drugs, especially therapeutic proteins like neurotro‐
phic factors have been encapsulated in this type of brain delivery system, however, the in vivo
hydrolysis of PLGA produce and acidic environment that result in a transient pH decline that
can compromise the proteins action and stability, and consequently the process of encapsula‐
tion and release from biodegradable microspheres must be carefully monitored [5, 21].
Polyethylene glycol (PEG)- based polymers are hydrophilic and water-swellable cross-linked
polymers with a high level of elasticity, making them ideal candidates for tissue engineering;
more importantly, the degradation rate of the implant can be controlled by simply altering the
chemistry of the cross-links within the polymer network [9]. PEG has a variety of applications
in drug delivery and tissue engineering, their hydrophilic and non ionic characteristics made
it relatively resistant to protein adsorption and highly biocompatible. In vitro, they can support
the survival of PC12 cells, fetal ventral mesencephalic neural cells, and human neural progen‐
itor cells. Furthermore, in culture, neural cells encapsulated into PEG-based hydrogels survive,
maintain phenotype, and extend processes indicating that the hydrogels are not themselves
cytotoxic [22, 23]. A recent study in primates found that PEG was completely degraded and
the neuroimmune response was less than that found in sham penetrated brains [22, 23].
2.2.2. Polyacrylates
Poly(2-hydroxethyl methacrylate) PHEMA, is one of the earliest polymer used as implantable
material. Polymerized from 2-hydroxyethyl methacrylate using free radical precipitation,
PHEMA forms a hydrogel biologically inert. One of the main concerns about PHEMA is its
low biodegradability, their biodegradation however can be manipulated by modifying the
porosity by photopatterning [24]. One of the earliest uses of PHEMA was as an artificial cornea,
or keratoprosthesis [25]. Methacrylic-acid- and acrylic-acid-based hydrogels have a high
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affinity for calcium and other alkaline earth metals, making them more prone to calcification,
thereby some calcification episodes has been found after in vivo implantation [9].
Poly(N-isopropylacrylamide)  (PNIPAAm)  has  been  widely  studied  as  a  temperature
responsive  drug  delivery  system.  It  has  the  particular  ability  to  undergo  a  thermally
induced phase transition at 32 °C that induces swelling in the polymer network. The phase
transition temperature can be tuned via copolymerization of more hydrophilic or hydropho‐
bic  co-monomers  to  achieve  desired  transitions  in  relevant  in  vivo  environments.  At
physiological temperatures, PNIPAAm homopolymer gels hold little water and show poor
elastic recovery [7, 26].
2.2.3. Poly(ω-hydroxyl acids)
The poly(ω-caprolactone) contains five (CH)2 units in the repeating unit, making the chains
much more flexible than PGA, which has one. Therefore, thermal and mechanical properties
decreased considerably compared to PGA. However, the rate of biodegradation is slow,
making it better suited to slow drug release applications such as one-year implantable
contraceptives, biodegradable wound closure staples, etc [27].
2.2.4. Poly(ortho esters)
Poly(ortho esters) (POE) undergo surface degradation, making them ideal as a drug-delivery
vehicle. Erosion process is confined predominantly to the surface layers; therefore controlled
drug release is possible as well as maintenance of an essentially neutral pH in the interior of
the matrix because acidic hydrolysis products diffuse away from the device. The rate of
degradation can be controlled by incorporating acidic or basic excipients into the polymer
matrix since the orthoester link is less stable in an acid than in a base [27]. The polymer is stable
at room temperature when stored under anhydrous conditions. Either solid or injectable
materials can be fabricated into different shapes such as wafers, strands, or microspheres that
allow drug incorporation by a simple mixing at room temperature and without the use of
solvents [28].
2.2.5. Poly(ester-amides)
Poly(ester-amides) (PEAs) combine the high degradability of polyesters with high thermal
stability and high modulus and tensil strength of polyamides [29], are non-toxic building
blocks and had excellent film forming properties. These polymers were mostly amorphous
materials,  combine the well-known absorbability  and biocompatibility  of  linear  aliphatic
polyesters with the high performance and the flexibility of potential chemical reactive sites
of  amide  of  polyamides  [20].  PEAs  can  be  functionalized  to  conjugated  different  drug,
peptides or molecules for cells signaling and had been used for microspheres and hydro‐
gels formation [29].
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2.2.6. Others
Poly(vinyl alcohol) PVA is prepared from the partial hydrolysis of poly(vinyl acetate). It can
be crosslinked into a gel either physically or chemically. In recent studies, PVA was photocured
to produce hydrogels as an alternative to chemical crosslinking [9]. PVA is similar to PHEMA
in having available pendant alcohol groups that act as attachment sites for biological mole‐
cules. In addition to having multiple attachment sites, PVA is also elastic and thus can induce
cell orientation or matrix synthesis by enhancing the transmission of mechanical stimuli to
seeded cells [30].
3. Biodegradation of polymeric biomaterials
Biodegradation process could be driven by chemical, physical, and biological interactions.
Biodegradation rate within an organism is related to the polymer characteristics and the place
in the body where will be exposed. Chemical degradation is influenced by composition and
molecular structure, polydispersity, crystallinity, surface area, hydrophilic or hydrophobic
characteristics. In general chemical degradation causes the deterioration of the main polymer
chains by random cleavage of covalent bounds, depolymerization or crosslinking of linear
polymers, interfering with regularly order chain and with cristallinity, decreasing the me‐
chanical properties [1]. Degradation can be by surface degradation or bulk degradation. In the
case of bulk degradation, water uptake by hydrophilic polymers is faster than the rate of
conversion of polymer into water-soluble materials, bulk degradation causes the collapse of
all the material since the degradation process occurs in throughout their volume. Surface
degradation appears in hydrophobic polymers, leaving the inner structure intact, these
polymers offers a better control of degradation rates [4].
Biodegradation in a biological environment may be defined as a gradual breakdown of a
material mediated by a specific biological activity; when materials are exposed to the body
fluids may undergo changes in their physicochemical properties as a result of chemical,
physical, mechanical, and biological interactions between the material and the surrounding
environment. A very important factor in biodegradation is the interaction with the immune
system and their specialized cells.
Polymeric materials can be degraded inside the body by at least three general mechanisms,
oxidation, hydrolytic, and enzymatic mechanism.
3.1. Hydrolytic mechanism
Hydrolytic degradation of polymers may be defined as the scission of chemical bonds in the
polymer backbone by the attack of water to form oligomers and finally monomers. This kind
of hydrolysis could not require of specific biological compounds as proteases, although many
of the biodegradation process by enzymatic mechanisms mentioned further are hydrolysis
reactions.
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All biodegradable polymers contain hydrolysable bonds like glycosides, esters, orthoesters,
anhydrides, carbonates, amides, urethanes, ureas; while materials with strong covalent bonds
in the backbone or non hydrolyzable groups have less biodegradable rates [31].
In the first step of hydrolytic mechanism, water contacts the water-labile bond, by either direct
access to the polymer surface or by imbibitions into the polymer matrix followed by bond
hydrolysis. Hydrolysis reactions may be catalyzed by acids, bases, or salts. After implantation,
the biomaterial absorbs water and swells, and degradation will progress from the exterior of
material towards its interior. In general, the first degradation reaction, even after contact with
water molecules, is the hydrolytic scission of the polymer chains leadings to a decrease in the
molecular weight. While degradation progress, the molecular weight of degradation products
is reduced by further hydrolysis which allows them to diffuse from the bulk material to the
surface and then to the solution, causing significant weight loss [31]. Rate of hydrolytic
degradation is modulated by hydrophilic characteristics of the polymers as mentioned before,
therefore materials such as PEG derived hydrogels have a high biodegradation rate [9]. In the
case of hydrolysis of aliphatic polyesters such as PLGA, the acid products accelerate biode‐
gradation due to autocatalysis [32].
3.2. Oxidation mechanism
Polymeric biomaterials could be degraded by oxidation when they are exposed to the body
fluids and tissues. It is well known that during inflammatory response to foreign materials,
inflammatory cells, particularly leukocytes and macrophages are able to produce highly
reactive oxygen species such as superoxide (O2-), hydrogen peroxide (H2O2), nitric oxide (NO),
and hypochlorous acid (HOCl). The oxidative effect of these species may cause polymer chain
scission and contribute to their degradation. For example superoxide could accelerate the
degradation of aliphatic polyesters by the cleavage of ester bonds via nucleophilic attack of
O2- [20, 31]. A resorbable suture of multifilament of poly(α-hydroxyester), commercially
available as Vicryl, for example, exhibited many irregular surface cracks after incubation for
7 and 14 days in an aqueous free radical solution prepared from H2O2 and FeSO4, while the
same suture in control solution did not have surface cracks, suggesting a role of free radicals
in the observed degradation [33]. It has also reported that polyurethanes are attacked initially
by neutrophils which secretes reactive oxygen species (ROS) and HOCl, one of the most
oxidative compounds [34].
3.3. Enzymatic mechanism
Enzymes are biological catalysts; they accelerate reaction rates in living organisms without
undergoing themselves any permanent change. Hydrolysis reactions may be catalyzed by
enzymes known as hydrolases, which include proteases, esterases, glycosidases, and phos‐
phatases, among others. For example, it has been shown that the degree of biodegradation of
polyurethanes, in the presence of cholesterol esterase enzyme, is about 10 times higher than
in the presence of buffer alone [35].
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Enzymatic surface degradation occurs when enzymes cannot penetrate the interior of the
polymer, due to high cross-link density or limited access to cleavage points, forcing the surface
or exterior bonds to cleave first. The mode of interaction between the enzymes and the
polymeric chains involves typically four steps:
• Diffusion of the enzyme from the bulk solution to the solid surface.
• Adsorption of the enzyme on the substrate, resulting in the formation of the enzyme–
substrate complex.
• Catalysis of the hydrolysis reaction
• Diffusion of the soluble degradation products from the solid substrate to the solution [20, 31].
Enzymatic degradation of natural origin polymer is held by the action of specific enzymes, for
example degradation of hyaluronic acid in mammals is carried out by the concerted action of
three enzymes: hyaluronidase, b-D-glucuronidase, and b-N -acetyl- D hexosaminidase; in the
case of chitin derivatives, lysozyme is the enzyme involved in their degradation inside the
body [31].
In vivo degradation rates of a polymers could be faster than in vitro; the higher in vivo degra
dation rate have been explained by the effects caused by cellular and enzymatic activities found
in the body [36]. In vitro degradation tests of polymers in simple aging media are normally
conducted to predict the performance of such polymers in the clinical situation; however,
taking into account the complexity of the body fluids, it is common to find different results
when the same materials are studied both in vitro and in vivo, mainly because of several
oxidation y enzymatic factors are absent in in vitro used medias.
4. Immune response and biodegradation
Immune system in the living organism is devoted to continuously surveillance the body to
detect self and non-self patterns. Immune system has cellular and molecular entities capable
to recognize and induce a response to eliminate the potential dangerous entity or non self
elements. There are two kinds of responses, innate immunity and adaptive immunity, the
former is a non specific and fast first reaction against a pathogen or a foreign body, while the
last is a slow, specific response to a first exposure pathogen or foreign body [37]. The two
systems of immunity are related, innate immunity system provides information to the adaptive
system by inflammatory mediators and cells such as macrophages and dendritic cells, which
process the antigens and present them to T cells of the adaptive immune system [38].
The interaction of inflammatory cells with biomaterials surface-adsorbed proteins constitutes
the major immune recognition system for biomaterials; therefore, the study of materials surface
properties to avoid the absorption of certain class of proteins has been determinant to under‐
stand their compatibility and their degradation process [39-41].
Foreign materials exposed to blood or plasma are immediately covered by proteins commonly
called opsonins, the most common opsonins are protein forming the complement system, a
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group of about 30 proteins that assemble to form a lityc complex and a recognizable system
for phagocytic cells [37]. The recognition through specific receptors in the phagocytic cells is
determinant to induce phagocytic and inflammatory response. Phagocytosis is one of the main
processes undertaken by innate immunity. Different kind of polymorphonuclear leukocytes
like neutrophils, and mononuclear leucocytes like monocytes, macrophages, and dendritic
cells, engulf the opsonized foreign material. Once inside the cell enzymes and oxidative
processes destroy them [37, 42].
The recognition of opsonized material by specific receptors in monocytes like Fc receptors,
mannose receptors or complement receptor triggers the rapid induction of proinflamatory
cytokines and recruitment of inflammatory cells [42]; while recognition of non opsinized
materials by scavenger receptors leads to non inflammatory phagocytic mechanism [43]. The
binding of other proteins like fibrin, collagen, albumim, fibronectin and vitronectin present in
the blood, plasma and surrounding tissue are also important to mediate an inflammatory
process and the recruitment of inflammatory cells [42].
Many biomaterials has to be implanted in the body through chirurgic procedures, the wound
healing process after the implantation induce the recruitment of inflammatory cells and an
acute inflammatory response, exposing the biomaterials to the immune system.
The first cells present in the injury site are neutrophils, and within a day or two monocytes,
macrophages and later lymphocytes arrive to the implantation site forming a chronic inflam‐
matory process (Figure 1).
If the inflammatory process continues and the biomaterial persist, a foreign body reaction can
appears, where multinucleated cell, resulted from the fusion of macrophages, invade the
implant site and collagen producing cells like fibroblasts arrives to form a fibrotic tissue around
the material forming a capsule [44].
In the case of biomaterials directly exposed to the blood, circulating monocytes, platelets,
leucocytes and dendritic cells recognize the materials inducing a similar oposinization and
inflammatory process, besides, the activation of platelets and blood coagulation system can
induce thrombotic occlusion and serious non desired effects in medical devices like artificial
valves, hearts or cardiac stents [44, 45].
Neutrophils and macrophages normally phagocyte foreign materials smaller than 10µm like
micro and nanoparticles, and degrade them after engulf into the phagolysosomes, a vesicles
containing numerous hydrolases within an acidic environment. When biomaterial particles
are large, among 10 to 100µm, multinucleated body giant cells can engulf and digest them,
however; when biomaterials are larger enough to avoid phagocytosis, frustrated phagocyte
response leads to secretion of numerous proteases, toxic oxygen derived metabolites or oxygen
radicals contained in phagocytic and phagolysosome degradatory vesicles [46-48]. The amount
of enzymes and radicals released depends on the size of the polymer particles, larger particles
induce greater amount of enzyme release. The phagocytable form of the biomaterial, particles
or powder, can also exert a differential response as compared for example with a less phago‐
cytable material like a film [44]. A recent study however, shows that the induction of pro-
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inflammatory cytokines in macrophages, is held after biomaterials contact with macrophages
cell membrane independently of the particles size [49].
Interestingly, fusion of macrophages into giant cells is dependent on the presence of interleu‐
kins like IL4, but also of the biomaterials surface properties, for example biomaterials with
hydrophilic and anionic surfaces induce the apoptosis or programmed cell dead of macro‐
phages, as compared with hydrophobic and cationic surfaces [50]. The formation of giant cells
by macrophages fusion is also modulated by the adsorption of plasma proteins like fibronectin
and vitronectin on the materials surface [40, 51].
It is important to mention that there is heterogeneity in the macrophages differentiated from
the arrived monocytes into the inflammation site; macrophages known as M1 are the “classi‐
cal” activated macrophages, stimulated by the TH1 cells or natural killers and microbial
products like lipopolysacharides. M1 produce cytotoxic products like reactive nitrogen and
oxygen species, and lead to chronic inflammation and formation of foreign body giant cells
[52, 53]. M2 macrophages are commonly termed “anti-inflammatory” macrophages. M2 are
induced by Interleukine IL4 and IL13 and release high amount of inflammatory suppressors
like interleukins IL10, M2 also suppress the nitric oxide release, thereby M2 macrophages are
related to immunosuppressive and protective activities like wound healing and fibrosis [53,
Figure 1. Inflammatory response after 3 days post injection of PEG-Silica gel into rat striatum. (A) Arrow indicates the
area of polymer implantation, (B) Phase contrast image of the implanted area, (C) Cresyl Violet staining of the area
marked in B, showing cell infiltration at the deepest injection area, (D) Higher magnification showing cell infiltration,
(E) Confocal image of a section immunostained to detect activated macrophages at the implanted area. Scales bars:
C= 50µm, D and E=100µm.
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54]. Interestingly biomaterials are able to modulate monocytes differentiation to anti-inflama‐
tory, pro regenerative M2 macrophages, or to avoid their differentiation into macrophages, or
the fusion of macrophages into multinucleated foreign body giant cells, diminishing the
undesirable inflammatory effects and the deleterious biodegradation [52].
Cholesterol esterase has been identified as an enzyme involved in the degradation of polyest‐
er(urethane)s and polyether- and polycarbonate-poly(urethane), this enzyme is also used as a
marker of monocyte derived macrophages [55]; some materials like degradable polar hydro‐
phobic ionic polyurethane (D-PHI) reduce the expression of esterase activity as compared with
cell cultures under polystyrene tissue culture plate, decrease pro-inflammatory interleukins
and cytokines like TNFbeta and increase the anti-inflammatory interleukins expression like
IL10, suggesting that monocytes can differentiate to an “anti-inflammatory” or M2 phenotypes
depending of the biomaterial and therefore influence the regenerative process after wound
healing [56].
Enzymes release by activated phagocytes influence the biomaterials degradation by different
rates depending upon many characteristic like chemical composition, homogeneity and
porosity. Activated macrophages and neutrophils secrete high amount of enzymes like
myeloperoxidases, lyzosime and metalloproteinases that contribute to the destruction of
invaders and to their migration into the injury or inflammation site; however in the case of
chronic inflammatory states enzymes secretion can be deleterious generating an extend and
irreversible damage to the tissue [57-59].
As mentioned before surface characteristic of polymeric materials are very important to induce
the recruitment, attachment and release of enzymes from neutrophils and macrophages;
hydrophilic surfaces induce the interaction with blood containing proteins like fibronectin,
fibrin, and albumin, inducing neutrophils adhesion to the proteins and stimulating the
degranulation behavior or delivery of primary and secondary granules containing high
amounts of enzymes.
For example macrophages cultured on polymers like poly(carbonate-) and poly(ether-)
urethanes secrete cholesterol esterase, carboxyl esterase, and serine protease mediating the
hydrolytic degradation of the polymers [34].
Hydrolases work under the low pH medium present in the phagolysosme, however when the
hydrolases are released outside the cell the extracellular buffer solutions could impair their
action; however a highly close interaction of macrophages with the materials forms a tight seal
with the substrate, thereby protecting the secreted substances from potential inhibitory
environment and therefore a transient and local decrease of pH at the site of phagocytosis
improves the hydrolases enzymatic activity [47, 60].
In vitro assays to analyze the hydrolytic degradation of biomaterials are not always very
accurate since paradoxically, the in vitro rates of degradation could be faster than in vivo rate
due to encapsulation of a polymer by fibrotic tissue after a foreign body reaction [36], therefore
it is important to perform in vitro plus in vivo assays in order to characterize the biodegradation
rates of polymeric material.
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The defense system against pathogens and foreign material includes the release of potent
oxidizing agents by activated neutrophils and macrophages. Many of the oxidative products
are released to the phagosome after their fusion with the lysosome once the leucocytes has
engulf the foreign invader; however, as mentioned before, these potent oxidants could be also
released to the extracellular space. After cells activation, oxidant are rapidly formed inside the
cells by a process known as oxidative burst that includes an elevated consume of oxygen and
the assembly of an enzymatic complex which catalyze the formation of superoxide anion O2-.
Superoxide anions are further dismutated to hydrogen peroxide H2O2, which in the presence
of myeloperoxidase generates very potent oxidizing agents like hypochlorous acid and
chloroamines. The induction of nitric oxide synthase (iNOS) and the production of reactive
nitrogen species and other oxidative species such as hydroxyl radical are also involved in the
oxidative mechanisms [61, 62]. In the case of human macrophages however non iNOS
induction was detected and therefore some differences as compared with mouse macrophages
are reported [62].
Besides their original antibacterial function therefore, the activation of macrophages after
contact with materials and the subsequent events like phagocytosis, release of cytokines and
foreign body reaction are determinant event in biodegradation of materials. In most of the
cases the delivery of high amount of reactive nitrogen and oxygen species and hydrolytic
enzymes in response to foreign material, are deleterious to biomaterials but also to the
surrounding tissues compromising the compatibility of biomaterials; hence fast biodegrada‐
tion rates can be beneficial to attenuate undesired inflammatory effects.
4.1. The particular case of the brain
Central nervous system (CNS) is the most highly protected organ in the body; it is located
behind the blood-brain barrier (BBB), a specialized structure formed by endothelial cells tightly
joint together, a basal membrane, perycytes, microglial cells and astrocytes endfeets forming
the glia limitants area [63]. Although the BBB provides an isolated environment for the brain
and represent a way to isolate and difficult the crosses of blood molecules and cells, brain is
not devoid of immune system monitoring and of interchange of proteins and cells, hence the
mentioned characteristics of BBB do not impair but delay the immune response [63].
Other characteristic of CNS immune response are the lack of classical dendritic cells in the
parenchyma of the CNS, and non conventional lymphoid drainage which impede the migra‐
tion and interaction of antigen presenting cell with the naïve memory T cell in the lymphoid
nodes; therefore, innate immune response in the brain cannot directly initiate the adaptive
immune response [64-66].
Immunological surveillance in the brain is held by several cell types, among them resident
microglia is considered the immune cells of the CNS. Microglia is generated independent of
the bone-marrow cells in adult organism, and is normally present in the brain in a non activated
form; however, although different from tissue resident macrophages, is also suitable of
activation and cell shape transformation from a ramified neuronal like morphology into a
rounded phagocytic macrophage type, able not only to engulf foreign material but to release
inflammatory mediators [67].
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Astrocytes are neural derived cells that participate in the homeostasis of the tissue, but after
an injury or foreign material presence, activated astrocytes deliver inflammatory mediators
that can modify the permeability of BBB allowing the entrance of blood circulating leukocytes.
Astrocytes can also phagocyte and form a glial scar or fibrous capsules to isolate the foreign
material [65, 66, 68].
Although the presence of conventional dendritic cells in the brain parenchyma has been a
controversial issue, recently it has reported the presence of them in the meninges and in
the endothelial cell layer that filters liquid from the blood and form the cerebrospinal fluid
named the choroid plexus, these cells are able to present antigens to induce adaptive im‐
mune response [69].
Perivascular cells are bone-marrow derived cells, monocytes and macrophages, located in the
space between blood vessels and glia limitants, and can act as antigen presenting cells. The
perivascular cells are the first and early arrival periphery cells entering to the brain parenchy‐
ma after an injury of inflammatory process [65, 70].
The particular immunological characteristics of CNS are complemented with the secretion, by
astrocytes and microglia, of some cytokines like transforming growth factor beta (TGFβ) which
suppress immune reaction, creating a particular immunosuppressive environment in the brain
parenchyma that attenuates inflammation and protect the brain from deleterious effects of
inflammation in neuronal integrity [71].
Polymeric biomaterials for CNS use are in expansion due to their properties as a drug de‐
livery vectors or as cells and nerves scaffolds. BBB is an impediment for parental drug ad‐
ministration;  therefore  the  use  of  biodegradable  polymer  for  in  situ  delivery  is  an
alternative to target the CNS. Biodegradable polymers offers a high advantage to control
the temporal and spatial delivery of drugs and cells, besides biodegradable polymers cir‐
cumvents the need of a second surgery to retire the vector as compared with non degrada‐
ble devices like mini pumps [5, 72, 73].
Some approaches using biodegradable polymers for neurodegenerative disorders like Par‐
kinson´s disease, Alzheimer and Huntington disease are being studied in different animal
models. For example the use of continuous releasing of neurotrophic factors like Glial De‐
rived Neurotrophic Factor (GDNF) in a rat model of Parkinson´s disease has shown to pro‐
tect  neurons  from  degenerative  process  [74].  Some  other  approaches  combining  the
encapsulation of cells and neurotrophic factor releasing microspheres have been recently
assayed, obtaining an amelioration of the asymmetric motor activity symptoms [75]. In the
case of the treatment of Alzheimer disease (AD), implantation of PLGA microspheres se‐
creting the Neuronal Growth Factor (NGF) promotes the survival of cholinergic neurons in
a rodent model that consist in the transaction of septo-hippocampal pathway to induces
similar symptoms to AD [76].
The disruption of BBB by injury in in situ delivery approaches can induce an immunological
reaction that not only implies the particular CNS immune characteristics, but the interaction
with periphery immune cells producing an extended inflammatory reaction; therefore, the
development of materials for low invasive delivery, like low viscosity injectable hydrogels,
Biodegradation - Life of Science16
has been one of the approaches [5]. Another recent and in expansion approach is the use of
functionalized polymeric micro and nanoparticles capable to cross the BBB, offering an
advantage to other invasive procedure; however some immunotoxicologycal non desired
aspects has to be considered, like the induction of inflammatory response after phagocytosis
by microglia and astrocytes, and the subsequent activation of innate inflammatory processes
that could rend to uncontrol and extensive damage to the brain and neurodegeneration [77-80].
Different polymers application requires different biodegradation rates, some drug delivery
vectors for example depends in the biodegradation rates to deliver the desired drug concen‐
trations, while in the case of cell scaffolds, the time of polymeric degradation could be longer
in order to maintain an appropriate environment for cell survival or for isolate them from
immune surveillance.
Delivery of growth factors that improves neuronal regeneration and projection using biode‐
gradable polymer such as poly(glycolic acid) (PGA), poly(lactic acid) (PLA), poly(lactic-co-
glycolic acid) (PLGA) and poly(e-caprolactone) (PCL) has been extensively studied. These
polymers degrade by non enzymatic hydrolytic cleavage of the backbone ester bond to alcohol
and carboxylic acid, the latter of which catalyzes further degradation and the biodegradation
rate can be controlled by the composition, molecular weight or size of the particles [81, 82].
The blend of polymers at different ratios modifies the biodegradation rates and hence their
delivery profiles, for example, PGA derived microspheres with different blend ratio to delivery
NGF showed different in vitro degradation rates: PLGA 50/50 degrade completely after 84 days
of in vitro incubation with phosphate buffered saline (PBS) at 37oC, PLGA 85/15 degrade by
80%, and PCL by less than 30% under the same conditions; this profile of degradation coincides
with the accumulative release of proteins, with the greatest accumulative release for PLGA
50/50; although the protein release profile is also influenced by the protein loading and the
water soluble products exposed to surrounding medium in in vitro assays [81].
Besides biodegradation, it is important to consider the biodegradation products generated, the
biodegradation of PGA derived polymers leads to the release of carboxylic acid groups that
in vitro can be buffered by PBS; however, after implantation in the brain, acidification of local
environment by biodegradation products can induce inflammatory response [81]. Inflamma‐
tory response induced by biodegradation products has been also studied by analyzing the
microglia and astrocytes response of triblocks of lactic acid-b-PEG-b-lactic acid copolymers
with two different degradable rates; it has shown an increase in reactive astrocytes in fast
degrading hydrogels as compared with low degrading rate gels. This result could be due to
the presence of more lactid acid as a product of degradation and a lactid acidosis in the
implanted area of fast degrading gel; however, in the case of activated microglia, there were
found a higher amount in slow and non degrade hydrogels [23]. In other report of the same
research group, long lasting studies shown less microglia and astrocytes activation when the
polymer has completely degraded, indicating that long term inflammatory response decrease
with fast degrading polymer [22].
The tissue damage induced by biodegradation products could have severe deleterious effects
in the CNS as reported for poly (methylidene malonate 2.1.2) (PMM 2.1.2); implanted micro‐
spheres of PMM 2.1.2 in rats striatum did not exert an important inflammatory response 1 or
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2 months after implantation, and only a transient and mild characteristic foreign body reaction
was observed. After 6 months post implantation however, when more degraded microspheres
were present, an important microglia and iNOS positive cells infiltrate where observed in the
implanted site together with extensive tissue damage. The extensive brain damage could be
due to the inflammatory stimulus exerted by acidic polyanions generated during degradation
process of PMM 2.1.2, and by the recruitment of activated macrophages and T cells with the
subsequent oxidative and enzyme release that contributes to the damage [83].
A delayed inflammatory response after biodegradation of PEG-Silica nanocomposite gel
implanted in the rat striatum was also observed [84]. PEG-Silica nanocomposite is suitable for
in vitro delivery of proteins involve in the stimulation of dopaminergic neurons, without cell
toxicity and no inflammatory response at short term in vivo implantation periods; however
after 30 days after implantation an increase in activated macrophages and gliosis could be
observed. In vitro assays using scattered Raman Spectroscopy after PEG-Silica incubation in
simulated body fluid, a solution with ions similar to extracellular body fluids, showed an
increase in PEG degradation and no modification of silica particles. PEG reduce protein
absorption on the surface of silica particles and therefore reduces their immunogenicity [85];
however after PEG degradation, silica nanoparticles could be exposed to the immune system
cells inducing an accumulation of activated macrophages and a glial reaction around the
implantation site [84].
Biocompatibility and biodegradation studies of the polymeric materials in the CNS requires
hence special considerations, the high vulnerability of neurons to long lasting chronic inflam‐
matory reactions, oxidative environments, and biodegradation products, make the use of
biodegradable polymeric material in CNS a challenge to avoid important deleterious effects
in this tissue [86, 87]; further, delayed immune response in the brain could rend to late
inflammation and therefore long term screening of CNS implanted polymers must be per‐
formed.
5. On Designed polymers for control biodegradation rates in biomedical
applications
The design of specific characteristic to modulate degradation has many biological applications.
The degradation of materials by non enzymatic hydrolysis is hard to regulate and only
polymers blends and copolymerization can modulate the biodegradation rates. Other ap‐
proaches to modulate biodegradation are modifications of chemical properties like crystallin‐
ity, hydrophobicity, and of surface characteristics like porosity [31].
The design of biomaterials for tissue engineering like cell scaffolds has to consider the
mechanical properties and an appropriate architecture to allow the growth, proliferation or
differentiation of cells; the modulation of biodegradation rate also contributes to the gradual
incorporation of extracellular matrix (ECM) components and cellular in growth [88]. It the
other hand, the design of cell responding delivery vectors for sequential delivery of different
growth factors are interesting approaches to exert an specific tissue activity, that could lead to
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a more biological control of drug delivery [89]. A more integrative approach hence is proposed
to manipulate biodegradation rates by cells interactions.
On designed polymers can modulate the degradation rate by enzymatic and oxidative
processes, and a vast numbers of reports can be found in the literature about this topic; in this
chapter we would mention some of the relevant strategies of the on purpose biodegradation
polymers and their future on biomedical applications.
The design of enzymatic biodegradable polymeric biomaterials has been explored in the last
years and is mainly intended to approach to the biological mechanisms that regulate the
functions of ECM. ECM is composed for many different types of proteins and has an instructive
role for cells; their biochemical and mechanical properties changes during development and
regeneration, and is specific for each tissue. Inspired in the structural and biochemical
characteristics of ECM, and by their mechanism of degradation during biological process, it
has been developed several polymers that mimic their dynamic characteristics. In vivo release
of growth factors (GF) is linked to ECM degradation, since usually GF are interacting with
ECM components as a way to control their activity, as well as for inducing a site specific action;
for example, by protecting them from enzymatic degradation, or by optimizing their biological
activity improving their interaction with their receptors [90, 91]. The control of polymer
biodegradation by enzymatic cleavage has been suggested for release of drugs and growth
factors in sequence and on demand by the cells of the polymer implantation site, or by the cells
introduced inside it. Among the most common enzymes used for on design biodegradable
polymer are the matrix metalloproteinases (MMP) enzyme family. MMP are zinc-dependent
proteins involved in degradation of ECM during several cell activities like migration, prolif‐
eration, adhesion, apoptosis and host defense; and involved in different tissue process like
immune reaction, wound healing, morphogenesis, tumor progression and angiogenesis [92].
Among the most common MMP used in biodegradable polymer design are elastase, plasmin
and collagenase.
The formation of new blood vessels requires of several growth factors like Vascular Endothelial
Growth Factor (VEGF), Fibroblast Growth Factor (FGF), and Transforming Growth Factor
(TGF). Blood vessels formation is an important process during wound repair, cell transplan‐
tation therapies, and for tissue engineering. Passive delivery of VEGF could lead to a low
efficacy because of a rapid clear from the site, and an over or insufficient dosage. Hubbell and
co workers pioneered the development of a metalloproteinase (MMP) sensitive PEG hydrogel
to deliver VEGF in response to cells, showing that cell demanded release of VEGF supports
the endothelial cells growth and the formation of completely remodeled vascularized tissue
at the site of the hydrogel implantation [93].
The enhancing of MMP proteolytic degradation of polymeric materials can also improve cell
differentiation and function; therefore their use as cell scaffold seems to be a promising
approach. Conjugating peptides containing multiple sequences of MMP proteolytic cleavage
to poly (ethylene glycol) diacrylate (PEGDA) hydrogels can control degradation rate and the
amount of endothelial cells invasion; hydrogels with peptides containing three different
proteolytic cleavage sites degraded faster and improved the amount and profundity of vessel
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invasion of human umbilical vein endothelial cells and human umbilical artery smooth muscle
cells, as compared with hydrogels conjugated to peptides with only one proteolytic cleavage
site [94].
The release of proteins combined with controlled biodegradable hydrogels can influence the
differentiation of stem cells to specific cell types, for example, using MMP sensitive hyaluronic
acid hydrogels containing bone morphogenetic protein (BMP) and mesenchymal stem cells,
induce almost a completely coverage of rat calvarian bone defect as compared with MMP
insensitive gel, showing the importance of cell responding scaffold to stimulate tissue regen‐
eration [95]. The use of PEG hydrogels linked to MMP-1 or collagenase sensitive peptides has
also shown a better differentiation of pre-adypocites cells, enhancing the triglyceride accu‐
mulation and the formation of adipose tissue like structures in this hydrogel intended for soft
tissue augmentation uses [96].
An important aspect during CNS regeneration is the axonal outgrowth of regenerating
neurons. After an injury the formation of glial scar and the presence of inhibitory proteins in
the ECM impair the projection of neurons to regenerate the damaged connections. MMP play
an important role in neuronal outgrowth during morphogenesis and regeneration by modu‐
lating the release of guiding factor or by degrading the inhibitory ECM proteins in the scar [97,
98]. In PEGylated fibrinogen hydrogels for example the presence of MMP3 inhibitor impairs
the axon outgrowth of dorsal root ganglion neurons; therefore MMP secretion is an important
step in the elongation of neurons inside the biomaterial [99]. The projection of neurons can be
improved by tuning the degradation rates of PEG-PLA hydrogels [100].
Improve of degradation by oxidative process is another interesting approach. The design of
biomaterials responsive to high oxidative environments can be used to modulate release of
drug for immunomodulation in pathological conditions like artheriosclerosis, implant
rejection sites or vaccines. For example the design of an ABA block copolymeric amphiphiles
with PEG as A block hydrophilic polymer and a B block hydrophobic poly(propylene sulfide)-
(PPS), exhibited hydrophobic-to hydrophilic changes when is oxidized in the presence of
H2O2, a behavior that can be used for controlled release applications like vaccine nanoparticles
[101, 102]. In a similar approach an oligo(proline)- crosslinked to a PEG, poly(ε-caprolactone),
and poly(carboxyl-ε-caprolactone) terpolymer system to form a polymeric scaffold were
synthesized, showing and increased biodegradation rate after expose to H2O2, or to activated
macrophages [103].
6. Conclusions
Manipulation of biodegradation process is fundamental not only to modulate the duration of
a material inside the body but to modulate biocompatibility, drug release, and cell invasion.
Mimic the dynamic and remarkably important extracellular environment by biomaterials is
another characteristic that could improved their functionality and biocompatibility. The
interaction among biomaterials and proteins or cells is relevant for functions like drug delivery
or cell proliferation and differentiation, and is one of the ongoing challenge that promise the
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development of specific and bio-responsive materials. Design of synthetic polymers that fully
integrate the knowledge accumulated from chemistry, material engineering and biological
disciplines like cell biology, biochemistry, and biophysics are the last paradigm in biomaterials.
In the particular case of biodegradation of polymeric biomaterials, the profound knowledge
about the chemical, physical and the biological mechanisms will render a more comprehensive
on purpose biomaterials design.
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